NSRX nasuspharma.com Year-over-year earnings per share growth for the last twelve months

Graphic logo of Nasus Pharma, Ltd. (NSRX)

Nasus Pharma Ltd (NSRX) is driving revenue growth through the monetization of nasal sprays, which is why the quarterly EPS growth trend on GURU.Markets includes the latest -356.40 parameter. This growth is based on streamlined temperature-controlled hub logistics and management's focus on developing rapid-response products for emergency medicine. Such systemic solutions minimize supply chain disruptions and strengthen the issuer's market position.

Nasus Pharma (NSRX) - Quarterly EPS earnings growth from 08/14/2025 to 11/17/2026

NSRX (Nasus Pharma): analytical breakdowns and indicator data

- market value and analyst target forecast:
Analysis of all company metrics:nasuspharma.com, NSRX
Finished products of nasuspharma.com

This indicator measures the dynamics of net earnings per share, eliminating temporary gaps between reporting periods through a daily calculation of growth. The current quarterly earnings per share growth value is -356.40, where any trend deceleration could foreshadow a decline in the capitalization of Nasus Pharma Ltd (NSRX) due to the dependence of profits on the efficiency of nasal drug delivery systems.

Who Nasus Pharma Ltd competes with

Indivior Corp (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharmaceutical Inc|CRON (thecronosgroup.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth canopygrowth.com|Quarterly EPS earnings growth HITI|ACB (Aurora Cannabis, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACHV (Achieve Life Sciences, Inc)|Skye Bioscience (SKYE) - Earnings per share growth in annualized terms for the last twelve months|Anebulo Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months InterCure|NTRB: Quarterly EPS earnings growth|India Globalization Capital - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MIRA Pharma|FLGC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months IMC (IMCC)|ADIL: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ARTL (Artelo)|Year-over-year earnings per one share growth for the last 12 months ENSC|Titan Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Greenlane Holdings|inmedpharma.com (INM) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months AKAN|Year-over-year earnings per share growth for the last twelve months Enveric Corp|Earnings per share growth in annualized terms for the last twelve months brightgreen.us BGXX|Year-over-year net earnings per share growth for the last 12 months HPCO (Hempacco Co Inc.)